Polymorphisms | Controls (%) | COVID-19 (%) | OR | 95% CI | P | ORa | 95% CI | P |
---|---|---|---|---|---|---|---|---|
ABO | ||||||||
O | 377 (36.39) | 98 (32.56) | 1.0 | – | – | 1.0 | – | – |
A | 330 (31.85) | 112 (37.21) | 1.30 | 0.95–1.77 | 0.090 | 1.31 | 0.96–1.79 | 0.086 |
B | 243 (23.46) | 61 (20.26) | 0.96 | 0.67–1.38 | 0.848 | 0.97 | 0.68–1.40 | 0.910 |
AB | 86 (8.30) | 30 (9.97) | 1.34 | 0.83–2.15 | 0.221 | 1.36 | 0.84–2.19 | 0.204 |
A + AB | 416 (40.15) | 142 (47.18) | 1.31 | 0.98–1.76 | 0.068 | 1.32 | 0.95–1.77 | 0.063 |
Rh | ||||||||
Rh+ | 955 (92.18) | 245 (81.40) | 1.0 | – | – | 1.0 | – | – |
Rh− | 81 (7.82) | 56 (18.60) | 2.97 | 1.86–3.89 | < 0.001 | 2.69 | 1.85–3.91 | < 0.001 |
Total | 1036 (100.0) | 301 (100.0) |